Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and ...

It's possible to have thyroid cancer for months or even years without knowing or being diagnosed. In contrast, anaplastic ...

Mutation-directed targeted therapy in combination with a PD-L1 inhibitor “is a promising strategy” to extend survival in patients with anaplastic thyroid cancer, according to researchers.

Tevimbra is under clinical development by BeiGene and currently in Phase II for Anaplastic Thyroid Cancer. According to GlobalData, Phase II drugs for Anaplastic Thyroid Cancer have a 36% phase ...

Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Anaplastic Thyroid Cancer.

program were used to calculate annual age-adjusted incidence and mortality rates for thyroid cancer (categorized as papillary, follicular, medullary, or anaplastic). Between 1973 and 2002 ...